128 related articles for article (PubMed ID: 27803168)
1. Mortality Rates in Patients With Chronic Hepatitis C and Cirrhosis Compared With the General Population: A Danish Cohort Study.
Hallager S; Brehm Christensen P; Ladelund S; Rye Clausen M; Lund Laursen A; Møller A; Schlicthting P; Galmstrup Madsen L; Gerstoft J; Lunding S; Elmegaard Grønbæk K; Bygum Krarup H; Weis N
J Infect Dis; 2017 Jan; 215(2):192-201. PubMed ID: 27803168
[TBL] [Abstract][Full Text] [Related]
2. Liver-related morbidity and mortality in patients with chronic hepatitis C and cirrhosis with and without sustained virologic response.
Hallager S; Ladelund S; Christensen PB; Kjær M; Thorup Roege B; Grønbæk KE; Belard E; Barfod TS; Madsen LG; Gerstoft J; Tarp B; Krarup HB; Weis N
Clin Epidemiol; 2017; 9():501-516. PubMed ID: 29123424
[TBL] [Abstract][Full Text] [Related]
3. Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit.
Álvaro-Meca A; Jiménez-Sousa MA; Boyer A; Medrano J; Reulen H; Kneib T; Resino S
BMC Infect Dis; 2016 Mar; 16():122. PubMed ID: 26979964
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up among Danish transfusion recipients identified in the national hepatitis C lookback.
Just SA; Grau K; Georgsen J; Weis N; Cowan S; Groenbaek K; Krarup H; Christensen PB;
Transfusion; 2012 Mar; 52(3):582-8. PubMed ID: 21883266
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans.
El-Serag HB; Kramer J; Duan Z; Kanwal F
J Viral Hepat; 2016 Sep; 23(9):687-96. PubMed ID: 27040447
[TBL] [Abstract][Full Text] [Related]
6. Sustained virological response: a milestone in the treatment of chronic hepatitis C.
Morisco F; Granata R; Stroffolini T; Guarino M; Donnarumma L; Gaeta L; Loperto I; Gentile I; Auriemma F; Caporaso N
World J Gastroenterol; 2013 May; 19(18):2793-8. PubMed ID: 23687416
[TBL] [Abstract][Full Text] [Related]
7. Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients.
Yen YH; Kuo FY; Kee KM; Chang KC; Tsai MC; Hu TH; Lu SN; Wang JH; Hung CH; Chen CH
Dig Liver Dis; 2019 Jan; 51(1):142-148. PubMed ID: 30076015
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study.
Huang YW; Yang SS; Fu SC; Wang TC; Hsu CK; Chen DS; Hu JT; Kao JH
Hepatology; 2014 Sep; 60(3):807-14. PubMed ID: 24919583
[TBL] [Abstract][Full Text] [Related]
9. Sustained virological response and metabolic risk factors are associated with mortality in patients with chronic hepatitis C.
Yen YH; Kee KM; Chen CH; Hu TH; Lu SN; Wang JH; Hung CH
PLoS One; 2019; 14(1):e0208858. PubMed ID: 30625158
[TBL] [Abstract][Full Text] [Related]
10. Diabetes Mellitus is Associated With Higher Risk of Developing Decompensated Cirrhosis in Chronic Hepatitis C Patients.
Saeed MJ; Olsen MA; Powderly WG; Presti RM
J Clin Gastroenterol; 2017 Jan; 51(1):70-76. PubMed ID: 27306942
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort).
Hsu WF; Tsai PC; Chen CY; Tseng KC; Lai HC; Kuo HT; Hung CH; Tung SY; Wang JH; Chen JJ; Lee PL; Chien RN; Lin CY; Yang CC; Lo GH; Tai CM; Lin CW; Kao JH; Liu CJ; Liu CH; Yan SL; Bair MJ; Su WW; Chu CH; Chen CJ; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Huang JF; Dai CY; Chuang WL; Yu ML; Peng CY
J Gastroenterol Hepatol; 2021 Oct; 36(10):2884-2892. PubMed ID: 33963615
[TBL] [Abstract][Full Text] [Related]
12. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
13. Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population.
Bruno S; Di Marco V; Iavarone M; Roffi L; Crosignani A; Calvaruso V; Aghemo A; Cabibbo G; Viganò M; Boccaccio V; Craxí A; Colombo M; Maisonneuve P
J Hepatol; 2016 Jun; 64(6):1217-23. PubMed ID: 27059129
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis in Denmark: A nationwide cohort study.
Hallager S; Ladelund S; Kjaer M; Madsen LG; Belard E; Laursen AL; Gerstoft J; Røge BT; Grønbaek KE; Krarup HB; Christensen PB; Weis N
J Viral Hepat; 2018 Jan; 25(1):47-55. PubMed ID: 28750141
[TBL] [Abstract][Full Text] [Related]
15. Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response.
Kim GA; Han S; Kim HD; An J; Lim YS
J Viral Hepat; 2017 Nov; 24(11):990-997. PubMed ID: 28499070
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of transfusion-acquired hepatitis C in an Australian bleeding disorders population.
Northcott MJ; Ong WL; Walsh M; McCarthy P; Belleli D; Tran H; Street A; Kemp W; Davis AK
Haemophilia; 2013 Nov; 19(6):847-52. PubMed ID: 23738855
[TBL] [Abstract][Full Text] [Related]
17. Establishing ultrasound based transient elastography cutoffs for different stages of hepatic fibrosis and cirrhosis in Egyptian chronic hepatitis C patients.
Elsharkawy A; Alboraie M; Fouad R; Asem N; Abdo M; Elmakhzangy H; Mehrez M; Khattab H; Esmat G
Arab J Gastroenterol; 2017 Dec; 18(4):210-215. PubMed ID: 29187317
[TBL] [Abstract][Full Text] [Related]
18. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
Prasad L; Spicher VM; Negro F; Rickenbach M; Zwahlen M;
J Viral Hepat; 2009 Sep; 16(9):644-9. PubMed ID: 19243494
[TBL] [Abstract][Full Text] [Related]
19. Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland--using spontaneous resolvers as the benchmark comparator.
Innes H; Hutchinson SJ; Obel N; Christensen PB; Aspinall EJ; Goldberg D; Krarup H; McDonald SA; McLeod A; Weir A; Omland LH
Hepatology; 2016 May; 63(5):1506-16. PubMed ID: 26773546
[TBL] [Abstract][Full Text] [Related]
20. Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis.
McDonald SA; Pollock KG; Barclay ST; Goldberg DJ; Bathgate A; Bramley P; Dillon JF; Fraser A; Innes HA; Kennedy N; Morris J; Went A; Hayes PC; Hutchinson SJ
J Viral Hepat; 2020 Mar; 27(3):270-280. PubMed ID: 31696575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
